168 203

Cited 0 times in

Thyroid carcinoma and focal lymphocytic thyroiditis share common features in ultrasonography : a diagnostic predictor model for discrimination

Other Titles
 비슷한 초음파 소견의 갑상선암과 림프구성 갑상선염의 구별에 대한 예측 모델 
Issue Date
Dept. of Medicine/석사
Background:Thyroid carcinoma is suspected when a nodule shows suspicious ultrasound (US) features. However, it is often difficult to discriminate focal lymphocytic thyroiditis (FLT) from thyroid carcinoma because of similar US findings. The objective was to discriminate FLT from thyroid carcinoma.Methods:One hundred thirty patients had undergone fine-needle aspiration biopsy (FNAB) and had shown thyroid nodules with suspicious US features. Papillary thyroid carcinoma (PTC) was confirmed by postoperative histology and FLT was confirmed through at least 2 FNAB. Clinical and biochemical findings, and US features were evaluated.Results:One hundred patients (76.9%) had PTC and 30 patients (23.1%) had FLT. US showed that the absence of calcification or “diffuse thyroid disease” (DTD) pattern was more common in patients with FLT than with PTC (P<0.001). The median TSH level was higher in FLT than PTC patients (P=0.016). The prevalence of antithyroid peroxidase antibody (TPO-Ab) or antithyroglobulin antibody (Tg-Ab) was more frequent in FLT than in PTC patients (P<0.001). To discriminate FLT from PTC, I created a diagnostic predictor model using logistic regression which included TSH, TPO- or Tg-Ab positivity, calcification, and DTD pattern. The model’s predictor probability of FLT rather than PTC was 85.4%.Conclusion:In patients presenting a thyroid nodule with suspicious US features, FLT is more likely than PTC when the nodule lacks calcification or is accompanied by a DTD pattern, the TSH level is  2.5 IU/dL, and the patient is the patient is TPO- or Tg-Ab positive.
Files in This Item:
T011905.pdf Download
Appears in Collections:
1. College of Medicine (의과대학) > Others (기타) > 2. Thesis
Yonsei Authors
Hwang, Se Na(황세나)
사서에게 알리기


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.